[google-translator]

GALT

Disorder: Metabolic

Condition: Classic Galactosemia (type I, Absent/Reduced Galactose-1-Phosphate Uridyltransferase)

Biomarker: Galactose-1-phosphate uridyltransferase (GALT)

The GALT assay is intended for the quantitative determination of the enzyme, galactose-1-phosphate uridyltransferase (GALT), in human whole blood. Measurement of GALT activity in newborn dried blood spots is used as a primary screen in the diagnosis and treatment of the life-threatening disease Galactosemia, an inborn error of carbohydrate metabolism. 

For more information, visit Galactosemia

Print Friendly, PDF & Email

PRODUCT HIGHLIGHTS

  • Results available in one shift – Allows for early identification of affected newborns
  • Prepared reagents are stable for 7 and 14 days – Competition boasts 48 hours
  • No false positive results due to G6PD deficiency – Reduced repeats
  • Colorimetric assay – Rapid visual correlation of positive results
  • Automated with other SPOTCHECK assays – Customizable workflow
  • 60 plate and 20 plate versions available – Throughput-based flexibility

For In Vitro Diagnostic Use.  This device is intended for use by trained, qualified laboratory personnel.

PRODUCT ORDERING INFORMATION

SPOTCHECK® NEONATAL GALT MICROPLATE REAGENT KIT CONFIGURATIONS

PART NO.DESCRIPTIONCONTENTS
81-4000-20K20 PlateReagents
81-4000-60K60 PlateReagents Only
81-4000P0060 PlateReagents, Microplates, Controls

AVAILABLE
ACCESSORIES

PART NO.PRODUCT NAMEDESCRIPTION
80-0900P4KSPOTCHECK® Blood Spot ControlsPositive (Deficient) Controls
80-0901P4KSPOTCHECK® Blood Spot ControlsNegative (Normal) Controls
900-0300P02MotherplateRound bottom, barcoded, 96 well microplates, case
900-0301P00READ PlateFlat bottom, 96 well microplates, case
DOWNLOAD OUR BROCHURE